schizophrenia

Johnson & Johnson’s stay-out-of-jail marketing for schizophrenia blockbuster Invega Sustenna raises eyebrows
Fierce Pharma
Thu, 02/15/18 - 11:46 pm
JNJ
drug marketing
schizophrenia
Invega Sustenna
FDA Clears Way for Filing on Psych Drug From Intra-Cellular, Shares Climb
Xconomy
Wed, 08/23/17 - 11:19 am
FDA
Intra-Cellular Therapies
lumateperone
schizophrenia
Alkermes says it's advancing 'full steam' with schizophrenia candidate
Fierce Biotech
Sat, 07/1/17 - 09:28 am
Alkermes
schizophrenia
ALKS 3831
Side Effect Weighs on Early Results for Alkermes’ Schizophrenia Drug
Xconomy
Fri, 06/30/17 - 09:40 am
Alkermes
schizophrenia
side effects
ALKS 3831
clinical trials
Alkermes claims a success in PhIII schizophrenia head-to-head, but where’s the benefit for patients?
Endpoints
Thu, 06/29/17 - 09:41 pm
Alkermes
schizophrenia
ALKS 3831
clinical trials
Can Alkermes' Latest Approval Spark a Rally?
Motley Fool
Wed, 06/7/17 - 11:25 am
Alkermes
drug approvals
Aristada
schizophrenia
Minerva's schizophrenia drug heads to late stages
BioPharma Dive
Tue, 05/16/17 - 10:31 pm
Minerva Neurosciences
MIN-101
schizophrenia
Why Recent Fanapt Ruling Is Important To Vanda
Seeking Alpha
Mon, 08/29/16 - 09:09 am
Fanapt
Vanda Pharmaceuticals
generics
schizophrenia
Vanda Pharmaceuticals fends off patent challenge from generic competitor
Bizjournals.com
Sat, 08/27/16 - 09:46 am
Fanapt
Vanda Pharmaceuticals
schizophrenia
FDA Grants Fanapt® Three Years of Marketing Exclusivity for Labeling Changes Relating to Maintenance Treatment of Schizophrenia
Yahoo
Wed, 06/15/16 - 10:37 am
FDA
Fanapt
Vanda Pharmaceuticals
market exclusivity
schizophrenia
With two PhIII schizophrenia trials in ruins and Alzheimer's on hold, Forum chops staff and considers options
Fierce Biotech
Sat, 03/26/16 - 12:43 pm
Forum Pharmaceuticals
schizophrenia
Alzheimer's disease
FRM-6124
layoffs
The FDA eases up on Forum's schizophrenia program with Alzheimer's trials still on hold
Fierce Biotech
Thu, 11/12/15 - 09:22 am
Forum Pharmaceuticals
FDA
schizophrenia
Alzheimer's disease
encenicline
Massive gov't study promotes smaller drug doses, more talk therapy for schizophrenia
BioPharma Dive
Tue, 10/20/15 - 05:56 pm
schizophrenia
Otsuka
Abilify
Novartis
Clozaril
Alkermes’s Aristada Demonstrates High Efficacy as Schizophrenia Therapy
Yahoo/Market Realist
Mon, 10/12/15 - 04:31 pm
Alkermes
Aristada
schizophrenia
Alkermes wins an FDA nod for its monthly schizophrenia drug
Fierce Biotech
Tue, 10/6/15 - 09:58 am
FDA
Alkermes
schizophrenia
Aristada
Abilify
Allergan and Richter win FDA approval for a once-rejected schizophrenia pill
Fierce Biotech
Thu, 09/17/15 - 05:21 pm
Allergan
Geodon Richter
FDA
cariprazine
antipsychotic
bipolar disorder
schizophrenia
GW sees a future in schizophrenia with its cannabis-based pipeline
Fierce Biotech
Tue, 09/15/15 - 11:35 am
GW Pharma
schizophrenia
cannabis
Lundbeck to advance schizophrenia drug solo after taking an ax to early-stage pipeline
Fierce Biotech
Thu, 08/20/15 - 09:14 am
Lundbeck
schizophrenia
Lu AF35700
Pfizer, SV give GSK spinout money to expand into schizophrenia research
Fierce Biotech
Thu, 07/16/15 - 09:38 am
GSK
Pfizer
schizophrenia
R&D
SV Life Sciences
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
BioPharma Dive
Mon, 07/13/15 - 09:51 am
FDA
Otsuka
Lundbeck
schizophrenia
Rexulta

Pages